Dysregulated NLRP3 inflammasome activation has been implicated in several central nervous system (CNS) disorders, including stroke, Alzheimer’s disease and Parkinson’s disease.19 This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.